News

11.11.2020. | We are happy to announce the creation of the official BSCC YouTube Channel. Our first upload being from the recent PPP conference held in Belgrade (the 3rd Serbian Public Private Partnership Conference, www.pppconference.rs), a presentation was given by Graham Coop…
Read more about

07.11.2020. | We are  happy to provide an update following our Brexit Briefing. Since the briefing, we have been working closely with the Serbian Chamber of Commerce (PKS) and the Foreign Investors Council (FIC). Yesterday Marko Čadez, President of PKS sent a letter to the Tatjana Matič,…
Read more about

07.11.2020. | As a member of the Roaming Solutions Group, Roaming Networks has established itself as one of the leading system integration companies in the Western Balkans in the field of ICT industry. They have always been committed in providing a complete and innovative solution…
Read more about

07.11.2020. | We are delighted to announce the appointment of one further director, Siniša Krajčinović  For the last few years, Siniša has acted as the authorised representative for the BSCC in Belgrade responsible for the legal and banking aspects of our Serbian representative…
Read more about

07.11.2020. | We appreciate all our newsletter subscriberss. For this reason we are working to try and ensure they recieve and are able to read it every fortnight, but we have noticed some issues that may make this difficult for you.  The first issue is our emails being marked…
Read more about

26.10.2020. | To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video …
Read more about

05.08.2020. | The BSCC is delighted to be joining the Belgrade based Foreign Investors Council (FIC) and supporting its efforts to reform the business environment.  The FIC was founded 18 years ago as an independent business association of foreign investors in Serbia.  Currently,…
Read more about

02.08.2020. | AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and…
Read more about